Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) traded up 5.1% during trading on Tuesday . The stock traded as high as $23.30 and last traded at $23.07. 7,171 shares were traded during trading, a decline of 91% from the average session volume of 82,682 shares. The stock had previously closed at $21.95.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International in a report on Thursday, March 27th. They issued an “overweight” rating on the stock.
Check Out Our Latest Stock Report on Ascentage Pharma Group International
Ascentage Pharma Group International Trading Up 5.8 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- Canada Bond Market Holiday: How to Invest and Trade
- Berkshire Hathaway Gains Defy Stock Market Slump
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Palantir Stock Builds Momentum on New Partnership
- Energy and Oil Stocks Explained
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
